Wednesday, 30 October 2013

Stem-Cell Therapy Misses Mark in Lymphoma Trial (CME/CE)

(MedPage Today) -- Progression of aggressive non-Hodgkin's lymphoma slowed significantly after autologous stem-cell transplantation, although overall survival did not improve, according to results of a randomized trial. via MedPageToday.com - medical news plus CME for physicians Read More Here..


Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/10/stem-cell-therapy-misses-mark-in.html

No comments:

Post a Comment